Abbvie Shares Owned by Institutions

ABBV
 Stock
  

USD 157.38  0.82  0.52%   

Abbvie Inc fundamentals help investors to digest information that contributes to Abbvie's financial success or failures. It also enables traders to predict the movement of Abbvie Stock. The fundamental analysis module provides a way to measure Abbvie's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abbvie stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Abbvie Shares Owned by Institutions Analysis

Abbvie's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
 2019 2020 2021 2022 (projected)
Receivables5.43 B8.82 B9.98 B10.76 B
Inventories1.81 B3.31 B3.13 B3.37 B
Shares Held by Institutions 
 = 
Funds and Banks 
Firms 
More About Shares Owned by Institutions | All Equity Analysis

Current Abbvie Shares Owned by Institutions

    
  70.80 %  
Most of Abbvie's fundamental indicators, such as Shares Owned by Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abbvie Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Abbvie Shares Owned by Institutions Driver Correlations

Understanding the fundamental principles of building solid financial models for Abbvie is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Shares Owned by Institutions. Since Abbvie's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Abbvie's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Abbvie's interrelated accounts and indicators.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Compare to competition

Based on the latest financial disclosure, 70% of Abbvie Inc are shares owned by institutions. This is 58.6% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The shares owned by institutions for all United States stocks is 80.57% lower than that of the firm.

Abbvie Shares Owned by Institutions Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abbvie's direct or indirect competition against its Shares Owned by Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abbvie could also be used in its relative valuation, which is a method of valuing Abbvie by comparing valuation metrics of similar companies.
Abbvie is currently under evaluation in shares owned by institutions category among related companies.

Abbvie Current Valuation Drivers

We derive many important indicators used in calculating different scores of Abbvie from analyzing Abbvie's financial statements. These drivers represent accounts that assess Abbvie's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Abbvie's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee183.07 K189.57 K262.73 K97.94 K230.84 K195.69 K
Revenue Per Employee972.97 K1.09 M1.11 M971.89 K1.12 M970.16 K
Average Assets68.07 B64.12 B65.62 B135.23 B148.47 B160.19 B
Earnings Before Interest Taxes and Depreciation Amortization EBITDA10.23 B8.11 B11.95 B12.15 B23.89 B25.78 B
Earnings Before Interest Taxes and Depreciation Amortization USD10.23 B8.11 B11.95 B12.14 B23.89 B25.77 B
Earnings before Tax7.73 B5.2 B8.43 B3.39 B12.98 B10.48 B
Average Equity5.7 B(2.8 B)(8.2 B)8.91 B13.81 B14.9 B
Enterprise Value183.74 B171.17 B158.69 B268.34 B307.91 B261.19 B
Free Cash Flow9.43 B12.79 B12.77 B16.79 B21.99 B23.73 B
Invested Capital38.87 B38.24 B66.08 B83.51 B69.94 B59.64 B
Invested Capital Average41.72 B38 B44.01 B81.18 B77.72 B62.54 B
Market Capitalization154.39 B138.67 B130.93 B189.17 B239.37 B205.71 B
Tangible Asset Value27.44 B22.46 B54.86 B34.56 B38.2 B35.35 B
Working Capital4.58 B(294 M)33.93 B(4.49 B)(7.27 B)(7.46 B)

Abbvie ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Abbvie's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Abbvie's managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Abbvie Institutional Holders

Institutional Holdings refers to the ownership stake in Abbvie that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Abbvie's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Abbvie's value.
Security TypeSharesValue
Zwj Investment Counsel IncCommon Shares278.6 K37.4 M
Zwj Investment Counsel IncCommon Shares275.2 K42.1 M
Zwj Investment Counsel IncCommon Shares275.1 K44.6 M
Zwj Investment Counsel IncCommon Shares274.2 K37.1 M
Zwj Investment Counsel IncCommon Shares267.2 K28.8 M
Zwj Investment Counsel IncCommon Shares258.9 K29.2 M
Zwj Investment Counsel IncCommon Shares125.1 K13.5 M

Abbvie Fundamentals

About Abbvie Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Abbvie Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbvie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbvie Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. Abbvie operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 50000 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Abbvie without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Valuation Now

   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module

Pair Trading with Abbvie

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbvie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbvie will appreciate offsetting losses from the drop in the long position's value.

Moving together with Abbvie

+0.78BIIBBiogen Inc TrendingPairCorr
+0.7ILMNIllumina Sell-off TrendPairCorr

Moving against Abbvie

-0.76SGENSeagen Inc Sell-off TrendPairCorr
The ability to find closely correlated positions to Abbvie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbvie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbvie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbvie Inc to buy it.
The correlation of Abbvie is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbvie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbvie Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbvie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Abbvie Piotroski F Score and Abbvie Altman Z Score analysis. Note that the Abbvie Inc information on this page should be used as a complementary analysis to other Abbvie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Abbvie Stock analysis

When running Abbvie Inc price analysis, check to measure Abbvie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbvie is operating at the current time. Most of Abbvie's value examination focuses on studying past and present price action to predict the probability of Abbvie's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbvie's price. Additionally, you may evaluate how the addition of Abbvie to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Is Abbvie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbvie. If investors know Abbvie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbvie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.24
Market Capitalization
280.2 B
Quarterly Revenue Growth YOY
0.033
Return On Assets
0.0909
Return On Equity
0.91
The market value of Abbvie Inc is measured differently than its book value, which is the value of Abbvie that is recorded on the company's balance sheet. Investors also form their own opinion of Abbvie's value that differs from its market value or its book value, called intrinsic value, which is Abbvie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbvie's market value can be influenced by many factors that don't directly affect Abbvie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbvie's value and its price as these two are different measures arrived at by different means. Investors typically determine Abbvie value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbvie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.